Table 2 Societal data for patients with a positive evolution of their ETDRS score over 24 months of follow-up (21.8% of patients): for positive ETDRS score evolution (first line): 3 corresponds to changes between 0 and + 5 letters; 4 corresponds to changes between + 5 and + 10 letters
From: Influence of new societal factors on neovascular age-related macular degeneration outcomes
Variable | Categories | Percentage |
|---|---|---|
Positive ETDRS Score evolution | 3 | 70.588 |
4 | 29.412 | |
Number of injections between baseline and M24 | 0 | 5.882 |
2 | 5.882 | |
5 | 17.647 | |
6 | 29.412 | |
8 | 5.882 | |
9 | 5.882 | |
10 | 5.882 | |
14 | 11.765 | |
15 | 5.882 | |
17 | 5.882 | |
Outpatient follow-up | No | 88.235 |
Yes | 5.882 | |
Sometimes | 5.882 | |
Family status | Couple | 41.176 |
Living alone | 52.941 | |
Family | 5.882 | |
Transportation to the clinic | Medicalized vehicle | 52.941 |
Taxi | 23.529 | |
Public transportation | 5.882 | |
Personal car | 17.647 | |
Commuting time to the clinic | 0 to 1 h | 47.059 |
1 to 2 h | 47.059 | |
More than 2 h | 5.882 | |
Low vision rehabilitation | No | 94.118 |
Yes | 5.882 | |
Daily reading | None | 11.765 |
Journal | 58.824 | |
Books | 23.529 | |
Computer | 5.882 | |
Health assurance covering 100% of expenses | No | 29.412 |
Yes | 70.588 | |
Economic burden of the treatment on the patient (0–10 scale) | 2 | 5.882 |
3 | 17.647 | |
4 | 29.412 | |
5 | 17.647 | |
6 | 17.647 | |
7 | 5.882 | |
8 | 5.882 | |
Painfulness of the treatment burden (0–10 scale) | 2 | 17.647 |
3 | 11.765 | |
4 | 23.529 | |
5 | 17.647 | |
6 | 5.882 | |
7 | 17.647 | |
8 | 5.882 |